Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study.
Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis – Biotech Investments
Medartis Holding AG / Key word(s): Personnel 09-Jul-2024 / 06:59 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is